Universe Pharmaceuticals INC (UPC)

NASDAQ: UPC · Real-Time Price · USD

4.270

-0.310 (-6.77%)

At close: Sep 1, 2026, 4:00 PM EDT

5.95

+1.68 (39.34%)

After-hours: Sep 1, 2026, 7:59 PM EDT

UPC Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 1, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	3	2	6	3	12	54
Market Cap Growth	39.21%	-58.99%	66.62%	-71.82%	-77.13%	-
Enterprise Value	-17	-37	1	-19	-12	20
Last Close Price	4.27	4.20	146.40	570.00	2034.00	8891.99

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 1, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
PE Ratio	-	-	-	-	-	4.75
PS Ratio	0.16	0.13	0.25	0.11	0.31	1.12
PB Ratio	0.04	0.04	0.13	0.12	0.27	0.91
P/TBV Ratio	0.05	0.04	0.13	0.12	0.27	0.91
P/FCF Ratio	-	-	-	3.23	-	-
P/OCF Ratio	-	-	-	3.10	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 1, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
EV/Sales Ratio	-	-	0.04	-	-	0.43
EV/EBITDA Ratio	-	-	-	-	-	1.46
EV/EBIT Ratio	-	-	-	-	-	1.51

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 1, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Debt / Equity Ratio	0.17	0.17	0.18	0.20	0.09	0.07
Debt / EBITDA Ratio	-	-	-	-	-	0.31
Debt / FCF Ratio	-	-	-	5.11	-	-
Net Debt / Equity Ratio	-0.35	-0.43	-0.47	0.01	-0.32	-0.30
Net Debt / EBITDA Ratio	12.11	10.15	2.85	-0.06	2.30	-1.24
Net Debt / FCF Ratio	1.57	4.58	2.21	0.18	10.70	1.12
Asset Turnover	0.23	0.26	0.42	0.64	0.62	0.97
Inventory Turnover	2.99	3.12	5.60	7.93	7.82	10.37
Quick Ratio	3.25	3.55	2.33	1.33	2.60	3.36
Current Ratio	4.05	4.07	2.54	1.84	3.17	4.50
Return on Equity (ROE)	-3.50%	-7.23%	-23.76%	-17.69%	-15.01%	28.39%
Return on Assets (ROA)	-1.72%	-2.66%	-9.14%	-4.90%	-6.77%	17.17%
Return on Invested Capital (ROIC)	-5.78%	-10.45%	-30.75%	-13.29%	-19.24%	41.01%
Return on Capital Employed (ROCE)	-3.60%	-5.20%	-16.80%	-14.20%	-15.10%	23.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 1, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Earnings Yield	-69.83%	-155.20%	-151.27%	-190.05%	-64.37%	21.07%
FCF Yield	-445.61%	-224.81%	-169.04%	30.98%	-11.36%	-29.02%
Buyback Yield / Dilution	-204.86%	-3174.93%	-	-	-	-

SEC Filings: 10-K · 10-Q